Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Total Costs & Expenses

$9.99M

Quarterly · Period ending: · USD

LCTX logo

LCTX Total Costs & Expenses

Latest reported$9.99M
LCTX Quarterly Total Costs & Expenses ($200.00K → $9.99M)
High-resolution chart · PNG

LCTX total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
9,992,000
9,318,000
13,156,000
7,467,000
22,545,000
8,007,000
7,978,000
7,619,000
7,275,000
8,105,000
8,450,000
7,951,000
8,249,000
9,028,000
8,554,000
8,249,000
8,787,000
11,633,000
29,198,000
9,045,000
7,521,000
7,343,000
6,048,000
7,067,000
6,501,000
7,604,000
7,704,000
8,639,000
11,071,000
12,940,000
10,278,000
10,621,000
9,750,000
11,762,000
10,132,000
9,976,000
10,699,000
11,641,000
12,011,000
9,945,000
14,909,000
24,344,000
22,255,000
17,944,000
14,068,000
14,067,638
14,848,795
12,681,112
13,528,340
11,628,819
13,095,059
10,755,584
8,639,296
8,904,056
7,576,499
6,950,109
7,112,995
6,547,486
7,091,367
5,375,419
5,736,547
4,850,516
5,173,949
3,272,988
2,995,702
2,093,249
-984,502
3,381,334
1,539,740
1,207,998
1,253,303
1,340,784
1,359,899
788,090
615,918
386,825
504,539
761,330
820,205
606,486
784,375
702,813
684,422
644,132
676,448
916,609
791,334
586,338
643,281
636,198
626,583
467,192
590,171
562,304
792,131
403,440
634,100
591,978
485,823
970,505
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.